CD34+ Leukemic Cells Assessed by Different CD:34 Monoclonal Antibodies

References

• Greaves M. F., Brown J., Molgaard H. V., Spurr N. K., Robertson D., Delia D., Sutherland D. R. Molecular features of CD34: a hemopoaietic progenitor cell-associated molecule. Leukemia 1992; 6: 31–36
   PubMed Web of Science ®Google Scholar
• Lansdorp P. M., Dragowska W. Maintenance of hematopoiesis in serum-free bone marrow cultures involves sequential recruitment of quiescent progenitors. Exper. Hematol. 1993; 21: 1321–1327
   PubMed Web of Science ®Google Scholar
• Silvestri F., Banavali S., Baccarani M., Preisler H. D. Progenitor cell associated antigen CD34: biology and clinical applications. Haematologica 1992; 77: 265–272
   PubMed Web of Science ®Google Scholar
• Peschle C. H., Koller U. Cluster report: CD34. Leucocyte typing IV: White cell differentiation antigens, W. Knapp, B. Dörken, W. R. Gilks, E. P. Rieber, R. E. Schmidt, H. Stein, A. E. G. Kr, Borne von dem. Oxford University Press, Oxford 1989
   Google Scholar
• Civin C. I., Trishniann T. M., Fackler M. J., Bernstein I. D., Bühring H. J., Campos L., Greaves M. F., Kamoun M., Katz D. R., Lansdorp P. M., Look A. T., Seed B., Sutherland D. R., Tindle R. W., Uchanska-Ziegler B. Report on the CD34 cluster workshop. Leucocyte typing IV: White cell differentiation antigens, W. Knapp, B. Dü, Gilks Urken, E. P. Rieber, R. E. Schmidt, H. Stein, A. E. G. Kr, Borne. von dem. Oxford University Press, Oxford 1989
   Google Scholar
• Egeland T., Gaüdemack G. Immunomagnetic isolation of CD34+ cells: methodology and monoclonal antibodies. Hematopoietic stem cell, E. Wunder, S. Serke, H. Solovat, P. Henon. AlphaMed Press., Dayton 1993; 141–148
   Google Scholar
• Wunder E., Sovalat H., Fritsch G., Silvestri F., Henon P., Serke S. Report on the European Workshop on peripheral blood stem cell determination and standardization-Mulhouse, France, February 6–8 and 14–15. J. Hematotherapy. 1992; 1: 13–142
   Google Scholar
• Sovalat H., Wunder E., Zimmermann R., Serke S. Multicentric determination of CD34+ cells. Hematopoietic stem cell, E. Wunder, S. Serke, H. Solovat, P. Henon. AlphnMed Press., Dayton 1993; 61–66
   Google Scholar
• Greaves M. F., Colman S. M., Bühring H. J., Campos L., Castoldi G. L., Garrido F., Gaudernack G., Girard J., Inglë P., As-Etsteve J., Invernizzi R., Knapp W., Lansdorp P. M., Lania F., Merle-Bèral H., Parravicini C., Razak K., Ruiz-Cabello F., Springer T. A., Van der Shoot C. E., Sutherland D. R. Report on the CD34 cluster workshop. Leucocyte typing V: White cell differentiation antigens, S. F. Schlossman, L. Boumsell, W. Gilks, J. M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R. L. Silverstein, T. A. Springer, T. F. Tedder, R. F. Tood. Oxford University Press, Oxford 1994
   Google Scholar
• Sutherland D. R., Marsh J. C. W., Davidson J., Baker M. A., Keating A., Mellors A. Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: implications for purification of CD34–positive progenitor cells. Exper. Hematol. 1992; 20: 590–599
   PubMed Web of Science ®Google Scholar
• Lanza F., Castoldi G. L. Large scale enrichment of CD34+ cells by percoll density gradients: a CML-based study design. Hematopoietic stem cells, E. Wunder, S. Serke, H. Solovat, P. Henon. AlphaMed Press., Dayton 1993; 255–270
   Google Scholar
• van't Veer M. B., Gratama J. W. on behalf of the SIHON study group. Quality assessment for immunophenotyping of leukaemias and lymphomas: the dutch experience. Leuk. Lymph. 1994; 13: 77–79, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Vogt R. F., Cross G. D., Henderson L. O., Phillips D. L. Model system evaluating fluorescein-labeled microbeads as internal standards to calibrate fluorescence intensity on flow cytometers. Cytometry 1989; 10: 294–302
   PubMedGoogle Scholar
• Brando B., Sommaruga E. Nationwide quality control trial on lymphocyte immunophenotyping and flow cytometer performance in Italy. Cytometry 1993; 14: 294–306
   PubMedGoogle Scholar
• Vogt R. F., Cross G. D., Phillips D. L., Henderson O., Hannon H. Interlaboratory study of cellular fluorescence intensity measurements with fluorescein labeled microbeads standards. Cytometry 1991; 12: 525–536
   PubMedGoogle Scholar
• Schwartz A. Fluorescent microbead standards (monograph). Flow Cytometry Standards Corporation. Research Triangle Park, NC 1988
   Google Scholar
• Olofsson T., Gartner I., Olsson I. Separation of human bone marrow cells in density gradients of polyvinpyrrolidone coated silica gel (Percoll). Scand, J. Haematol. 1980; 24: 254–262
   PubMedGoogle Scholar
• Ellis W. M., Georgiou G. M., Roberton D. M., Johnson G. R. The use of discontinuous Percoll gradients to separate populations of cells from human bone marrow and peripheral blood. J. Immunol. Method 1984; 66: 9–16
   PubMed Web of Science ®Google Scholar
• Thomas T. E., Abraham S., Phillips G., Lansdorp P. A simple procedure for large scale density separation of bone marrow cells for transplantation. Transplantation 1992; 53: 1163–1165
   PubMed Web of Science ®Google Scholar
• Lanza F., Bi S., Castoldi G. L., Goldman J. M. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia. Leukemia 1993; 7: 1570–1575
   PubMed Web of Science ®Google Scholar
• Liesveld J. L., Winslow J. M., Frediani K. E., Ryan D. H., Abboud C. N. Expression of integrins and examination of their adhesive function in normal and leukemic hematopoietic cells. Blood 1993; 81: 112–121
   PubMed Web of Science ®Google Scholar
• Moore M. A. S. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood 1991; 78: 1–19
   PubMed Web of Science ®Google Scholar
• Lanza F., Rigolin G. M., Moretti S., Latorraca A., Castoldi G. L. Prognostic value of immunophenotipic characteristic of blasts cells in acute myeloid leukemia. Leuk. Lymph. 1994; 13: 81–85, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Roscoe R. A., Rybka W. B., Winkelstein A., Houston A. M., Kiss J. E. Enumeration of CD34+ hematopoietic stem cells for reconstitution following myeloablative therapy. Cytometry 1994; 16: 74–19
   PubMedGoogle Scholar
• Banavali S., Silvestri F., Hulette B., Hurtubise P., Srivastava A., Civin C., Preisler H. Expression of hematopoietic progenitor cell associated antigen CD34 in chronic myeloid leukemia. Leuk. Rex 1991; 15: 603–608
   PubMed Web of Science ®Google Scholar
• Barnett M. J., Eaves C. J., Phillips G. L., Kalousek D. K., Klingemann H. G., Lansdorp P. M., Reece D. E., Shepherd J. D., Shaw G. J., Eaves A. C. Successful autografting in chronic myeloid leukemia after maintenance of marrow in culture. Bone Marrow Transplant. 1989; 4: 345–351
   PubMed Web of Science ®Google Scholar
• Verfaille C. M., Miller W. J., Boylan K., McGlave P. B. Selection of benign primitive hematopoietic progenitors in chronic myelogeneous leukemia on the basis of HLA-DR antigen expression. Blood 1992; 79: 1003–1010
   PubMed Web of Science ®Google Scholar
• Dunbar C., Stewart F. M. Separating the wheat from the chaff selection of benign hematopoietic cells in chronic myeloid leukemia. Blood 1992; 79: 1107–1110
   PubMed Web of Science ®Google Scholar
• Srour E. F., Brandt H. E., Leemhuis T., Ballas C. B., Hoffman R. Relationship between cytokine-dependent cell cycle progression and MHC class II antigen expression by human CD34+ HLA-DR- bone marrow cells. J. Immunol. 1992; 148: 815–820
   PubMed Web of Science ®Google Scholar
• Cashman J. D., Eaves A. C., Raines E. W., Ross R., Eaves C. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long term human marrow cultures, I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-B. Blood 1990; 75: 96–101
   PubMed Web of Science ®Google Scholar
• Lanza F., Bi S., Goldman J. M. Similarity of p53 expression by CD34+ cells in chronic myeloid leukemia and normal progenitors detected by flow cytometry. Blood 1992; 80: 1857–1858
   PubMed Web of Science ®Google Scholar
• Lanza F., Fagioli F., Gavioli R., Spisani S., Malavasi F., Castoldi G. L. Evaluation of CRI expression in neutrophils from chronic myeloid leukemia.: relationship between prognosis and cellular activity. Br. J. Haematol. 1991; 77: 66–72
   PubMed Web of Science ®Google Scholar
• Lanza F., Castoldi G. L. Complement receptor 1 (CRI) expression in chronic myeloid leukemia. An overview. Leuk. Lymph. 1992; 8: 35–41
   PubMed Web of Science ®Google Scholar
• Dowding C. R., Gordon M. Y., Goldman J. M. Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia. Exper. Hematol. 1988; 16: 171–175
   PubMed Web of Science ®Google Scholar